Trial Profile

Treatment of elderly patients ([greater than] 60 years) with acute myeloblastic leukemia or advanced MDS (RAEB-T): An open randomized study to test the efficacy of G-CSF-priming and a feasibility trial of dose-reduced allogeneic transplantation and of autologous stem cell transplantation.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cytarabine; Etoposide; Granulocyte colony-stimulating factors; Idarubicin
Indications Acute myeloid leukaemia; Myelodysplastic syndromes
Focus Therapeutic Use

24 Mar 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
02 Dec 2005 New trial record.
26 Oct 2005 Biomarkers information updated

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com